Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells-Reference-Cited by-同舟云学术

Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells

Published:2017-08-10 Issue:59 Volume:8 Page:99482-99494
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Sakata Jun¹,Utsumi Fumi¹,Suzuki Shiro¹,Niimi Kaoru¹,Yamamoto Eiko²,Shibata Kiyosumi³,Senga Takeshi⁴,Kikkawa Fumitaka¹,Kajiyama Hiroaki¹

Affiliation:

1. Department of Obstetrics and Gynecology, Graduate School of Medicine, Nagoya University, Nagoya, Japan

2. Department of Healthcare Administration, Graduate School of Medicine, Nagoya University, Nagoya, Japan

3. Department of Obstetrics and Gynecology, Banbuntane Hotokukai, Fujita Health University, Fujita, Japan

4. Division of Tumor Biology, Graduate School of Medicine, Nagoya University, Nagoya, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer;The Journal of Pathology: Clinical Research;2024-04-22

2. STAT3 phosphorylation inhibitor Bt354 exhibits anti‐neoplastic activity in glioblastoma multiforme cells;Environmental Toxicology;2024-02-28

3. TRPM7 transactivates the FOSL1 gene through STAT3 and enhances glioma stemness;Cellular and Molecular Life Sciences;2023-08-29

4. UBE2T regulates epithelial–mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer;Journal of Ovarian Research;2022-09-10

5. The EMT-activator ZEB1 is unrelated to platinum drug resistance in ovarian cancer but is predictive of survival;Human Cell;2022-07-06